Selected research
Industry Growth & Trends
Global Multiplex Molecular Diagnosis Technology Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Multiplex Molecular Diagnosis Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Multiplex Molecular Diagnosis Technology is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Multiplex Molecular Diagnosis Technology is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Multiplex Molecular Diagnosis Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Multiplex Molecular Diagnosis Technology market include Siemens, Hologic, Thermo Fisher Scientific, Koninklijke Philips N.V., NeuroLogica, Shimadzu Medical, GENERAL ELECTRIC, Sysmex and Canon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Multiplex Molecular Diagnosis Technology market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Multiplex Molecular Diagnosis Technology market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Multiplex Molecular Diagnosis Technology market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Multiplex Molecular Diagnosis Technology.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Multiplex Molecular Diagnosis Technology market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Multiplex Molecular Diagnosis Technology Market by Company
Siemens
Hologic
Thermo Fisher Scientific
Koninklijke Philips N.V.
NeuroLogica
Shimadzu Medical
GENERAL ELECTRIC
Sysmex
Canon
FUJIFILM Holdings
Bio-Rad Laboratories
Roche Diagnostics
Luminex Corporation
Abbott Laboratories
QIAGEN
Multiplex Molecular Diagnosis Technology Segment by Type
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low Density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Multiplex Molecular Diagnosis Technology Segment by Application
Hospital
Outpatient Surgery Centre
Others
Multiplex Molecular Diagnosis Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multiplex Molecular Diagnosis Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Multiplex Molecular Diagnosis Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multiplex Molecular Diagnosis Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Multiplex Molecular Diagnosis Technology companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Real-time PCR
- Nested PCR with Melt Curve Analysis
- PCR with Low Density Microarray
- PCR with Liquid Phase Bead Array
- PCR with Electrochemical Detection
Applications
- Hospital
- Outpatient Surgery Centre
- Others
Companies covered
- Siemens
- Hologic
- Thermo Fisher Scientific
- Koninklijke Philips N.V.
- NeuroLogica
- Shimadzu Medical
- GENERAL ELECTRIC
- Sysmex
- Canon
- FUJIFILM Holdings
- Bio-Rad Laboratories
- Roche Diagnostics
- Luminex Corporation
- Abbott Laboratories
- QIAGEN
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Multiplex Molecular Diagnosis Technology Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Multiplex Molecular Diagnosis Technology Market Size by Region (2021-2032)
- 1.4.1 Global Multiplex Molecular Diagnosis Technology Market Size by Region (2021-2026)
- 1.4.2 Global Multiplex Molecular Diagnosis Technology Market Size by Region (2027-2032)
- 1.5 Key Regions Multiplex Molecular Diagnosis Technology Market Size (2021-2032)
- 1.5.1 North America Multiplex Molecular Diagnosis Technology Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Multiplex Molecular Diagnosis Technology Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size Growth Rate (2021-2032)
- 1.5.4 South America Multiplex Molecular Diagnosis Technology Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Size Growth Rate (2021-2032)
2 Multiplex Molecular Diagnosis Technology Market by Type
- 2.1 Type Introduction
- 2.1.1 Real-time PCR
- 2.1.2 Nested PCR with Melt Curve Analysis
- 2.1.3 PCR with Low Density Microarray
- 2.1.4 PCR with Liquid Phase Bead Array
- 2.1.5 PCR with Electrochemical Detection
- 2.2 Global Multiplex Molecular Diagnosis Technology Market Size by Type
- 2.2.1 Global Multiplex Molecular Diagnosis Technology Market Size Overview by Type (2021-2032)
- 2.2.2 Global Multiplex Molecular Diagnosis Technology Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Multiplex Molecular Diagnosis Technology Market Size Forecasted by Type (2027-2032)
- 2.3 Global Multiplex Molecular Diagnosis Technology Market Size by Regions
- 2.3.1 North America Multiplex Molecular Diagnosis Technology Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Multiplex Molecular Diagnosis Technology Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Multiplex Molecular Diagnosis Technology Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Multiplex Molecular Diagnosis Technology Market Size Breakdown by Type (2021-2026)
3 Multiplex Molecular Diagnosis Technology Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Outpatient Surgery Centre
- 3.1.3 Others
- 3.2 Global Multiplex Molecular Diagnosis Technology Market Size by Application
- 3.2.1 Global Multiplex Molecular Diagnosis Technology Market Size Overview by Application (2021-2032)
- 3.2.2 Global Multiplex Molecular Diagnosis Technology Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Multiplex Molecular Diagnosis Technology Market Size Forecasted by Application (2027-2032)
- 3.3 Global Multiplex Molecular Diagnosis Technology Market Size by Regions
- 3.3.1 North America Multiplex Molecular Diagnosis Technology Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Multiplex Molecular Diagnosis Technology Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Multiplex Molecular Diagnosis Technology Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Multiplex Molecular Diagnosis Technology Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Multiplex Molecular Diagnosis Technology Industry Trends
- 4.2 Multiplex Molecular Diagnosis Technology Industry Drivers
- 4.3 Multiplex Molecular Diagnosis Technology Industry Opportunities and Challenges
- 4.4 Multiplex Molecular Diagnosis Technology Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Multiplex Molecular Diagnosis Technology Revenue (2021-2026)
- 5.2 Global Multiplex Molecular Diagnosis Technology Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Multiplex Molecular Diagnosis Technology Key Company Headquarters & Area Served
- 5.4 Global Multiplex Molecular Diagnosis Technology Company, Product Type & Application
- 5.5 Global Multiplex Molecular Diagnosis Technology Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Multiplex Molecular Diagnosis Technology Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Multiplex Molecular Diagnosis Technology Players Market Share by Revenue in 2025
- 5.6.3 2025 Multiplex Molecular Diagnosis Technology Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Siemens
- 6.1.1 Siemens Company Information
- 6.1.2 Siemens Business Overview
- 6.1.3 Siemens Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Siemens Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.1.5 Siemens Recent Developments
- 6.2 Hologic
- 6.2.1 Hologic Company Information
- 6.2.2 Hologic Business Overview
- 6.2.3 Hologic Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Hologic Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.2.5 Hologic Recent Developments
- 6.3 Thermo Fisher Scientific
- 6.3.1 Thermo Fisher Scientific Company Information
- 6.3.2 Thermo Fisher Scientific Business Overview
- 6.3.3 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.3.5 Thermo Fisher Scientific Recent Developments
- 6.4 Koninklijke Philips N.V.
- 6.4.1 Koninklijke Philips N.V. Company Information
- 6.4.2 Koninklijke Philips N.V. Business Overview
- 6.4.3 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.4.5 Koninklijke Philips N.V. Recent Developments
- 6.5 NeuroLogica
- 6.5.1 NeuroLogica Company Information
- 6.5.2 NeuroLogica Business Overview
- 6.5.3 NeuroLogica Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 NeuroLogica Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.5.5 NeuroLogica Recent Developments
- 6.6 Shimadzu Medical
- 6.6.1 Shimadzu Medical Company Information
- 6.6.2 Shimadzu Medical Business Overview
- 6.6.3 Shimadzu Medical Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Shimadzu Medical Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.6.5 Shimadzu Medical Recent Developments
- 6.7 GENERAL ELECTRIC
- 6.7.1 GENERAL ELECTRIC Company Information
- 6.7.2 GENERAL ELECTRIC Business Overview
- 6.7.3 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.7.5 GENERAL ELECTRIC Recent Developments
- 6.8 Sysmex
- 6.8.1 Sysmex Company Information
- 6.8.2 Sysmex Business Overview
- 6.8.3 Sysmex Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Sysmex Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.8.5 Sysmex Recent Developments
- 6.9 Canon
- 6.9.1 Canon Company Information
- 6.9.2 Canon Business Overview
- 6.9.3 Canon Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Canon Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.9.5 Canon Recent Developments
- 6.10 FUJIFILM Holdings
- 6.10.1 FUJIFILM Holdings Company Information
- 6.10.2 FUJIFILM Holdings Business Overview
- 6.10.3 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.10.5 FUJIFILM Holdings Recent Developments
- 6.11 Bio-Rad Laboratories
- 6.11.1 Bio-Rad Laboratories Company Information
- 6.11.2 Bio-Rad Laboratories Business Overview
- 6.11.3 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.11.5 Bio-Rad Laboratories Recent Developments
- 6.12 Roche Diagnostics
- 6.12.1 Roche Diagnostics Company Information
- 6.12.2 Roche Diagnostics Business Overview
- 6.12.3 Roche Diagnostics Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Roche Diagnostics Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.12.5 Roche Diagnostics Recent Developments
- 6.13 Luminex Corporation
- 6.13.1 Luminex Corporation Company Information
- 6.13.2 Luminex Corporation Business Overview
- 6.13.3 Luminex Corporation Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Luminex Corporation Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.13.5 Luminex Corporation Recent Developments
- 6.14 Abbott Laboratories
- 6.14.1 Abbott Laboratories Company Information
- 6.14.2 Abbott Laboratories Business Overview
- 6.14.3 Abbott Laboratories Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Abbott Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.14.5 Abbott Laboratories Recent Developments
- 6.15 QIAGEN
- 6.15.1 QIAGEN Company Information
- 6.15.2 QIAGEN Business Overview
- 6.15.3 QIAGEN Multiplex Molecular Diagnosis Technology Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 QIAGEN Multiplex Molecular Diagnosis Technology Product Portfolio
- 6.15.5 QIAGEN Recent Developments
7 North America
- 7.1 North America Multiplex Molecular Diagnosis Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 7.3 North America Multiplex Molecular Diagnosis Technology Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Multiplex Molecular Diagnosis Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 8.3 Europe Multiplex Molecular Diagnosis Technology Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Multiplex Molecular Diagnosis Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 10.3 South America Multiplex Molecular Diagnosis Technology Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst